Terry-Allison T, Montgomery R I, Whitbeck J C, Xu R, Cohen G H, Eisenberg R J, Spear P G
Department of Microbiology-Immunology, Northwestern University Medical School, Chicago, Illinois 60611, USA.
J Virol. 1998 Jul;72(7):5802-10. doi: 10.1128/JVI.72.7.5802-5810.1998.
The purpose of this study was to determine whether a cell surface protein that can serve as coreceptor for herpes simplex virus type 1 (HSV-1) entry, herpesvirus entry mediator (previously designated HVEM but renamed HveA), also mediates HSV-1-induced cell-cell fusion. We found that transfection of DNA from KOS-804, a previously described HSV-1 syncytial (Syn) strain whose Syn mutation was mapped to an amino acid substitution in gK, induced numerous large syncytia on HveA-expressing Chinese hamster ovary cells (CHO-HVEM12) but not on control cells (CHO-C8). Antibodies specific for gD as well as for HveA were effective inhibitors of KOS-804-induced fusion, consistent with previously described direct interactions between gD and HveA. Since mutations in gD determine the ability of HSV-1 to utilize HveA for entry, we examined whether the form of virally expressed gD also influenced the ability of HveA to mediate fusion. We produced a recombinant virus carrying the KOS-804 Syn mutation and the KOS-Rid1 gD mutation, which significantly reduces viral entry via HveA, and designated it KOS-SR1. KOS-SR1 DNA had a markedly reduced ability to induce syncytia on CHO-HVEM12 cells and a somewhat enhanced ability to induce syncytia on CHO-C8 cells. These results support previous findings concerning the relative abilities of KOS and KOS-Rid1 to infect CHO-HVEM12 and CHO-C8 cells. Thus, HveA mediates cell-cell fusion as well as viral entry and both activities of HveA are contingent upon the form of gD expressed by the virus.
本研究的目的是确定一种可作为1型单纯疱疹病毒(HSV-1)进入的共受体的细胞表面蛋白——疱疹病毒进入介质(先前命名为HVEM,但现重命名为HveA)是否也介导HSV-1诱导的细胞-细胞融合。我们发现,转染来自KOS-804(一种先前描述的HSV-1合胞体(Syn)株,其Syn突变被定位到gK中的一个氨基酸替换)的DNA,可在表达HveA的中国仓鼠卵巢细胞(CHO-HVEM12)上诱导产生大量大的合胞体,但在对照细胞(CHO-C8)上则不会。针对gD以及HveA的特异性抗体是KOS-804诱导融合的有效抑制剂,这与先前描述的gD和HveA之间的直接相互作用一致。由于gD中的突变决定了HSV-1利用HveA进入细胞的能力,我们研究了病毒表达的gD形式是否也影响HveA介导融合的能力。我们构建了一种携带KOS-804 Syn突变和KOS-Rid1 gD突变的重组病毒,该突变显著降低了病毒通过HveA进入细胞的能力,并将其命名为KOS-SR1。KOS-SR1 DNA在CHO-HVEM12细胞上诱导合胞体的能力明显降低,而在CHO-C8细胞上诱导合胞体的能力有所增强。这些结果支持了先前关于KOS和KOS-Rid1感染CHO-HVEM12和CHO-C8细胞的相对能力的研究结果。因此,HveA介导细胞-细胞融合以及病毒进入,并且HveA的这两种活性都取决于病毒表达的gD形式。